During the past decade, LKH Salzburg, Landesklinik fuer Dermatologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LKH Salzburg, Landesklinik fuer Dermatologie" are "Psoriasis" (2 trials). Many other conditions were trialed in "LKH Salzburg, Landesklinik fuer Dermatologie" in a lesser frequency.

Most popular intervention types in "LKH Salzburg, Landesklinik fuer Dermatologie" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials), "CP-690,550" (1 trials), "Etanercept 50 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "LKH Salzburg, Landesklinik fuer Dermatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LKH Salzburg, Landesklinik fuer Dermatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in LKH Salzburg, Landesklinik fuer Dermatologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LKH Salzburg, Landesklinik fuer Dermatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".